416 related articles for article (PubMed ID: 24383403)
21. CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.
Wang S; Wu J; Zhao W; Li M; Li S
FASEB J; 2023 Apr; 37(4):e22848. PubMed ID: 36906285
[TBL] [Abstract][Full Text] [Related]
22. Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.
Zhu X; Zhong J; Zhao Z; Sheng J; Wang J; Liu J; Cui K; Chang J; Zhao H; Wong S
Oncotarget; 2015 Sep; 6(28):25320-38. PubMed ID: 26318291
[TBL] [Abstract][Full Text] [Related]
23. P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition.
Cao Y; Han Q; Li J; Jia Y; Zhang R; Shi H
J Cancer; 2020; 11(10):2788-2799. PubMed ID: 32226497
[No Abstract] [Full Text] [Related]
24. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.
Bordoli MR; Stiehl DP; Borsig L; Kristiansen G; Hausladen S; Schraml P; Wenger RH; Camenisch G
Oncogene; 2011 Feb; 30(5):548-60. PubMed ID: 20856199
[TBL] [Abstract][Full Text] [Related]
25. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.
Pankova D; Jiang Y; Chatzifrangkeskou M; Vendrell I; Buzzelli J; Ryan A; Brown C; O'Neill E
EMBO J; 2019 Jul; 38(13):e100532. PubMed ID: 31268606
[TBL] [Abstract][Full Text] [Related]
26. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.
Smirnova T; Bonapace L; MacDonald G; Kondo S; Wyckoff J; Ebersbach H; Fayard B; Doelemeyer A; Coissieux MM; Heideman MR; Bentires-Alj M; Hynes NE
Oncotarget; 2016 Dec; 7(50):82289-82304. PubMed ID: 27793045
[TBL] [Abstract][Full Text] [Related]
27. Autosomal-dominant myopia associated to a novel P4HA2 missense variant and defective collagen hydroxylation.
Napolitano F; Di Iorio V; Testa F; Tirozzi A; Reccia MG; Lombardi L; Farina O; Simonelli F; Gianfrancesco F; Di Iorio G; Melone MAB; Esposito T; Sampaolo S
Clin Genet; 2018 May; 93(5):982-991. PubMed ID: 29364500
[TBL] [Abstract][Full Text] [Related]
28. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
29. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
[TBL] [Abstract][Full Text] [Related]
30. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
[TBL] [Abstract][Full Text] [Related]
31. Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylases.
Shi R; Gao S; Smith AH; Li H; Shao M; Shangguan J; Zhang J; Xu J; Ye J; Graham LM; Li C
Biochem Biophys Res Commun; 2020 Sep; 529(4):1011-1017. PubMed ID: 32819558
[TBL] [Abstract][Full Text] [Related]
32. Collagen prolyl 4-hydroxylase isoenzymes I and II have sequence specificity towards different X-Pro-Gly triplets.
Salo AM; Rappu P; Koski MK; Karjalainen E; Izzi V; Drushinin K; Miinalainen I; Käpylä J; Heino J; Myllyharju J
Matrix Biol; 2024 Jan; 125():73-87. PubMed ID: 38081527
[TBL] [Abstract][Full Text] [Related]
33. P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis.
Zhu M; Peng R; Liang X; Lan Z; Tang M; Hou P; Song JH; Mak CSL; Park J; Zheng SE; Huang A; Ma X; Chen R; Chang Q; Logothetis CJ; Jain AK; Lin SH; Katayama H; Hanash S; Wang G
Oncogene; 2021 Oct; 40(41):6049-6056. PubMed ID: 34471235
[TBL] [Abstract][Full Text] [Related]
34. Collagen prolyl 4-hydroxylases modify tumor progression.
Shi R; Gao S; Zhang J; Xu J; Graham LM; Yang X; Li C
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):805-814. PubMed ID: 34009234
[TBL] [Abstract][Full Text] [Related]
35. Vernonia cinerea Less. inhibits tumor cell invasion and pulmonary metastasis in C57BL/6 mice.
Pratheeshkumar P; Kuttan G
Integr Cancer Ther; 2011 Jun; 10(2):178-91. PubMed ID: 21059623
[TBL] [Abstract][Full Text] [Related]
36. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
37. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
38. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
39. Reduced Bone Mass in Collagen Prolyl 4-Hydroxylase
Tolonen JP; Salo AM; Finnilä M; Aro E; Karjalainen E; Ronkainen VP; Drushinin K; Merceron C; Izzi V; Schipani E; Myllyharju J
JBMR Plus; 2022 Jun; 6(6):e10630. PubMed ID: 35720665
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.
Elia I; Rossi M; Stegen S; Broekaert D; Doglioni G; van Gorsel M; Boon R; Escalona-Noguero C; Torrekens S; Verfaillie C; Verbeken E; Carmeliet G; Fendt SM
Nature; 2019 Apr; 568(7750):117-121. PubMed ID: 30814728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
